Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments
PaperCitations, authors & open-access status
Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 274 citations, 2015 year and closed oa status.
274
Citations
2015
Year
closed
OA Status